Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVRx (CVRX)
NASDAQ:CVRX
CVRx (CVRX) Stock Price & Analysis
126 Followers
CVRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.40 - $33.14
Previous Close$9.61
Volume189.15K
Average Volume (3M)385.22K
Market Cap
$207.53M
Enterprise Value$157.78M
Total Cash (Recent Filing)$80.11M
Total Debt (Recent Filing)$30.36M
Price to Earnings (P/E)―
Beta1.64
Next Earnings
Jul 29, 2024EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.48
Shares Outstanding21,595,576
10 Day Avg. Volume402,731
30 Day Avg. Volume385,220
Standard Deviation0.26
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)3.53
Price to Sales (P/S)20.67
Price to Cash Flow (P/CF)-5.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.75
Enterprise Value/Gross Profit4.78
Enterprise Value/Ebitda-3.24
Forecast
1Y Price Target
$13.50Price Target Upside40.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
CVRx News
Bulls Say, Bears Say
Bulls Say
LeadershipNew CEO Hykes will strongly enhance the long-term outlook.
Market PotentialCVRx has a novel technology with robust clinical evidence in a multi-billion-dollar market with a significant unmet need.
Revenue GrowthRevenue growth can reaccelerate as new CEO Hykes and team stabilize the organization.
Bears Say
Pricing PressureThe proposed CMS change would force CVRX to lower the average selling price from $29,000-$30,000 to about $25,000 for Medicare patients.
Regulatory ChangesReimbursement for Barostim in the outpatient setting will be reduced from $45,000 to around $31,000.
Sales PerformanceQ1 results fell short of expectations due to unexpected sales force turnover, negatively impacting morale and performance.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CVRX FAQ
What was CVRx’s price range in the past 12 months?
CVRx lowest stock price was $6.40 and its highest was $33.13 in the past 12 months.
What is CVRx’s market cap?
Currently, no data Available
When is CVRx’s upcoming earnings report date?
CVRx’s upcoming earnings report date is Jul 29, 2024 which is tomorrow.
How were CVRx’s earnings last quarter?
CVRx released its earnings results on Apr 30, 2024. The company reported -$1.04 earnings per share for the quarter, missing the consensus estimate of -$0.541 by -$0.499.
Is CVRx overvalued?
According to Wall Street analysts CVRx’s price is currently Undervalued.
Does CVRx pay dividends?
CVRx does not currently pay dividends.
What is CVRx’s EPS estimate?
CVRx’s EPS estimate is -$0.55.
How many shares outstanding does CVRx have?
CVRx has 21,595,575 shares outstanding.
What happened to CVRx’s price movement after its last earnings report?
CVRx reported an EPS of -$1.04 in its last earnings report, missing expectations of -$0.541. Following the earnings report the stock price went down -34.752%.
Which hedge fund is a major shareholder of CVRx?
Among the largest hedge funds holding CVRx’s share is Royce & Associates LLC. It holds CVRx’s shares valued at 2M.
---
CVRx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.50 (40.48% Upside)
$13.50 (40.48% Upside)
Blogger Sentiment
Bullish
CVRX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 8.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 5.2%
Last 30 Days ▲ 5.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.19%
12-Months-Change
Fundamentals
Return on Equity
-62.70%
Trailing 12-Months
Asset Growth
-13.46%
Trailing 12-Months
Company Description
CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases.
---
CVRX Earnings Call
Q1 2024
0:00 / 0:00
---
CVRX Stock 12 Month Forecast
Average Price Target
$13.50
▲(40.48% Upside)
Technical Analysis
Best Analysts Covering CVRX
1 Year
1 Year Success Rate
8/15 ratings generated profit
1 Year Average Return
+17.68%
reiterated a buy rating 3 months ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of +17.68% per trade.
---